[Systemic sarcoidosis after treatment with pegylated interferon-alpha].
A few cases of sarcoidosis have been reported in the course of chronic hepatitis C, with or without alpha-interferon treatment. We report a 54-year-old woman who presented a typical sarcoidosis in this context. The sarcoidosis involved skin, lungs and eyes. There are data in the literature supporting a pathogenic link between alpha-interferon and sarcoidosis: alpha-interferon possessing a non-specific immunologic inductor. The treatment of the sarcoidosis in this context is difficult and has to be adjusted to both the severity of the sarcoidosis and the viral hepatitis. Although sarcoidosis induced by alpha-interferon is rare, clinicians must be aware of this association.
Le Bras
M
M
Service de médecine interne, CHU de Nantes, Nantes cedex, France.
Hervier
B
B
Wastiaux
H
H
Masseau
A
A
Durant
C
C
Jossic
F
F
Hamidou
M
M
D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D012507:Sarcoidosis / Q000139:chemically induced*
D016898:Interferon-alpha